Skip to main content
NREBLR Ethics & IRB Observatory

NIH ClinRegs LBR-18 · GHS Index 5.2 · ICH-GCP E6(R3)

Clinical Research Ethics, IRB Governance & Global Health Security

An independent biomedical governance repository preserving Liberia NREB-LR statutory baselines alongside modern ICH-GCP E6(R3), Declaration of Helsinki (2024), and dual-use biosafety frameworks.

Physicians and clinical trial coordinators reviewing printed trial protocols and digital monitors in a modern hospital research center
Multidisciplinary REC protocol deliberation and cross-site compliance audit.
Statutory Quorum
11 / 21 Voting Seats
Full Board SLA
28-42 Calendar Days
PHEIC Fast-Track
10-15 Days (AVAREF)
SUSAR Reporting
7d Fatal · 15d Serious
Direct Regulatory Summary

National Research Ethics Committees (RECs) and Institutional Review Boards (IRBs) protect human research participants by enforcing independent protocol review, majority quorum rules (11 of 21 members under Liberia NREB statutory baselines), risk-benefit equipoise, and documented informed consent prior to clinical trial initiation under ICH-GCP E6(R3) and CIOMS 2016 standards.

Reference baseline: NIAID ClinRegs Liberia Profile & ICH Efficacy Guidelines.

Core Governance & Citation Index

Preserved Archival Citations

REC Organization Structure & Review Pathways /organization-structure/

21-member multidisciplinary quorum mechanics, Full Board vs. Expedited triage, and interactive dossier builder (ClinRegs LBR-18).

Ethical Mandate & Dual-Use Biosafety /mission-vision/

Participant welfare baselines, GHS Index Indicator 5.2 DURC clearance, and the interactive ICH-GCP risk checklist (ClinRegs LBR-12).

PREVAIL Ebola Trials & AVAREF Archive /archive/

West African outbreak clinical trial lineage, AVAREF joint review harmonization, and Liberia regulatory continuity.

Global Trial & IRB Standards

Helsinki (2024) & CIOMS Informed Consent /ethics/

Operationalizing plain-language ICFs, pediatric assent (ages 7-17), placebo justifications, and eConsent audit trails.

ICH-GCP E6(R3) RBQM & ICH E17 MRCTs /governance/

Quality by Design (QbD), Critical-to-Quality oversight, TMF readiness, and 7-day / 15-day SUSAR escalation rules.

Biosecurity, MTAs & Outbreak Review /biosecurity/

Material Transfer Agreements, Nagoya ABS benefit-sharing, pathogen custody, and 5-15 day PHEIC emergency ethics review.

Authoritative Reference Benchmarks

Comparison of Core Clinical Research Ethics & Regulatory Frameworks
Framework Primary Scope Review & Consent Mandate Target Turnaround
Liberia NREB Baseline National human-subjects trial oversight 21-member board; majority quorum (11) 28-42 days
ICH-GCP E6(R3) Interventional drug & biologic trials Risk-proportionate IRB review & eConsent 21-35 days
Declaration of Helsinki (2024) Medical research involving human participants Independent REC approval prior to enrollment Pre-FPI gate
WHO / AVAREF Joint Review Multi-country epidemic & vaccine trials Harmonized national REC + NRA dossier 10-15 days (PHEIC)